pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
deupirfenidone
Idiopathic Pulmonary Fibrosis
Celea Therapeutics
0 catalysts
Phase 2
devimistat
devimistat [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Cornerstone Pharmaceuticals Inc
0 catalysts
Phase 2
dibotatug
Leukemia
Dren Bio Inc
0 catalysts
Phase 2
dilanubicel
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
← prev
page 35 of 50
next →
131
Pain89
Neurology1
Deverra Therapeutics Inc
0 catalysts
Phase 2
dimesna
dimesna [INN]
Non-Small Cell Lung Cancer
$LTRNLantern Pharma Inc.
0 catalysts
Phase 2
dimethyltryptamine
Treatment Resistant Depression
$ATAIAtaiBeckley Inc.
0 catalysts
Phase 2
dinutuximab beta
dinutuximab beta [INN]
Ewing Sarcoma
Recordati SpA
0 catalysts
Phase 2
diranersen
diranersen [INN]
Alzheimer's Disease
$BIIBBIOGEN INC.
0 catalysts
Phase 2
disitamab vedotin
Metastatic Transitional (Urothelial) Tract Cancer
Receptor tyrosine-protein kinase erbB-2Tubulin
$PFEPFIZER INC
0 catalysts
Phase 2
disufenton sodium
Recurrent Malignant Glioma
Oblato Inc
0 catalysts
Phase 2
divesiran
divesiran [INN]
Polycythemia Vera
$SLNSilence Therapeutics plc
0 catalysts
Phase 2
dorocubicel
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Cordex Biologics Inc
0 catalysts
Phase 2
dronabinol + palmidrol
dronabinol + palmidrol [INN]
Tourette Syndrome
Evero Health Ltd
0 catalysts
Phase 2
dubodencel
dubodencel [INN]
Glioblastoma Multiforme (GBM)
Diakonos Oncology Corp
0 catalysts
Phase 2
durvalumab + IPH-5201
Non-Small Cell Lung Cancer
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
dutogliptin tartrate
Post-Myocardial Infarction
Recardio Inc
0 catalysts
Phase 2
duvalgagene otiparvovec
Fabry Disease
$FDMT4D Molecular Therapeutics, Inc.
0 catalysts
Phase 2
efarindodekin alfa
efarindodekin alfa[INN]
Cervical Cancer
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 2
efdoralprin alfa
efdoralprin alfa [INN]
Alpha-1 Antitrypsin Deficiency (A1AD)
$SNYSanofi
0 catalysts
Phase 2
efgitasialase alfa
Breast Cancer
Palleon Pharmaceuticals Inc
0 catalysts
Phase 2
efineptakin alfa
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
NeoImmuneTech Inc
0 catalysts
Phase 2
efinopegdutide
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Glucagon receptorGlucagon-like peptide 1 receptor
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
efocipegtrutide
efocipegtrutide [INN]
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Hanmi Pharmaceuticals Co Ltd
0 catalysts
Phase 2
efpegerglucagon
efpegerglucagon [INN]
Hyperinsulinemia
Hanmi Pharmaceuticals Co Ltd
0 catalysts
Phase 2
efzofitimod
efzofitimod [INN]
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease)
$ATYRaTYR PHARMA INC
0 catalysts
Phase 2
egalognastat
egalognastat [INN]
Progressive Supranuclear Palsy
Grupo Ferrer Internacional SA
0 catalysts
Phase 2
elecoglipron
Type 2 Diabetes
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
elezanumab
Traumatic Spinal Cord Injury
Repulsive guidance molecule A
$ABBVAbbVie Inc.
0 catalysts
Phase 2
elifactant
Neonatal Respiratory Distress Syndrome
Chiesi Farmaceutici SpA
0 catalysts
Phase 2
elironrasib
Non-Small Cell Lung Cancer
$RVMDRevolution Medicines, Inc.
0 catalysts